Literature DB >> 20546985

A meta-analytic review of prolonged exposure for posttraumatic stress disorder.

Mark B Powers1, Jacqueline M Halpern, Michael P Ferenschak, Seth J Gillihan, Edna B Foa.   

Abstract

Two decades of research demonstrate the efficacy of exposure therapy for posttraumatic stress disorder (PTSD). The efficacy of prolonged exposure (PE), a specific exposure therapy program for PTSD that has been disseminated throughout the world, has been established in many controlled studies using different trauma populations. However, a meta-analysis of the effectiveness of PE for PTSD has not been conducted to date. The purpose of the current paper is to estimate the overall efficacy of PE for PTSD relative to adequate controls. We included all published randomized controlled trials of PE vs. control (wait-list or psychological placebo) for the treatment of PTSD in adolescents or adults. Treatments were classified as PE if they included multiple sessions of imaginal and in vivo exposure and were based on the manualized treatment developed by Foa, Rothbaum, Riggs, and Murdock (1991). Thirteen studies with a total sample size of 675 participants met the final inclusion criteria. The primary analyses showed a large effect for PE versus control on both primary (Hedges's g=1.08) and secondary (Hedges's g=0.77) outcome measures. Analyses also revealed medium to large effect sizes for PE at follow-up, both for primary (Hedges's g=0.68) and secondary (Hedges's g=0.41) outcome measures. There was no significant difference between PE and other active treatments (CPT, EMDR, CT, and SIT). Effect sizes were not moderated by time since trauma, publication year, dose, study quality, or type of trauma. The average PE-treated patient fared better than 86% of patients in control conditions at post-treatment on PTSD measures. PE is a highly effective treatment for PTSD, resulting in substantial treatment gains that are maintained over time. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20546985     DOI: 10.1016/j.cpr.2010.04.007

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  185 in total

Review 1.  Treating Posttraumatic Stress Symptoms Among People Living with HIV: a Critical Review of Intervention Trials.

Authors:  Carmen P McLean; Hayley Fitzgerald
Journal:  Curr Psychiatry Rep       Date:  2016-09       Impact factor: 5.285

2.  Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?

Authors:  Nina K Rytwinski; Cari B Rosoff; Norah C Feeny; Lori A Zoellner
Journal:  Behav Res Ther       Date:  2014-08-01

3.  Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD.

Authors:  Edna B Foa; Seth J Gillihan; Richard A Bryant
Journal:  Psychol Sci Public Interest       Date:  2013-05

4.  Harnessing reconsolidation to weaken fear and appetitive memories: A meta-analysis of post-retrieval extinction effects.

Authors:  M Alexandra Kredlow; Leslie D Unger; Michael W Otto
Journal:  Psychol Bull       Date:  2015-12-21       Impact factor: 17.737

Review 5.  Virtual Reality-Enhanced Extinction of Phobias and Post-Traumatic Stress.

Authors:  Jessica L Maples-Keller; Carly Yasinski; Nicole Manjin; Barbara Olasov Rothbaum
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

6.  Enhancing Completion of Cognitive Processing Therapy for Posttraumatic Stress Disorder with Quetiapine in Veterans with Mild Traumatic Brain Injury: a Case Series.

Authors:  Muhammad R Baig; Jennifer L Wilson; Jennifer A Lemmer; Robert D Beck; Alan L Peterson; John D Roache
Journal:  Psychiatr Q       Date:  2019-06

7.  Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Authors:  Edna B Foa; Anu Asnaani; David Rosenfield; Laurie J Zandberg; Peter Gariti; Patricia Imms
Journal:  J Consult Clin Psychol       Date:  2017-06-01

8.  Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder.

Authors:  Yasutaka Matsumoto; Shigeru Morinobu; Shigeto Yamamoto; Tomoya Matsumoto; Shiro Takei; Yosuke Fujita; Shigeto Yamawaki
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

9.  High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder.

Authors:  Belinda Graham; Natalia M Garcia; Mark S Burton; Andrew A Cooper; Peter P Roy-Byrne; Matig R Mavissakalian; Norah C Feeny; Lori A Zoellner
Journal:  Br J Psychiatry       Date:  2018-10-25       Impact factor: 9.319

10.  Using Prolonged Exposure and Cognitive Processing Therapy to Treat Veterans with Moral Injury-Based PTSD: Two Case Examples.

Authors:  Philip Held; Brian J Klassen; Michael B Brennan; Alyson K Zalta
Journal:  Cogn Behav Pract       Date:  2017-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.